Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted hearts

Human Gene Therapy

Volumn 18, Issue 5, 2007, Pages 401-412

  Stevens, Kelly R ^a,b   Rolle, Marsha W ^c   Minami, Elina ^b,d   Ueno, Shuichi ^b   Nourse, Marilyn B ^a,b   Virag, Jitka I ^e   Reinecke, Hans ^b   Murry, Charles E ^a,b  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AP 20187; BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN; DNA; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FK 506 BINDING PROTEIN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL THERAPY; CHIMERA; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIMERIZATION; DNA SYNTHESIS; DOSE RESPONSE; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; GENETIC TRANSDUCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; MALE; MOUSE; MYOBLAST; NONHUMAN; NUDE MOUSE; RETROVIRUS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; CELL LINE; CELL PROLIFERATION; DIMERIZATION; GENE THERAPY; MICE; MICE, NUDE; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC;

ANIMALIA; MUS MUSCULUS;

EID: 34249785406     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.161     Document Type: Article

References (32)

1. BOILLY, B., VERCOUTTER-EDOUART, A.S., HONDERMARCK, H., NURCOMBE, V., and LE BOURHIS, X. (2000). FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev. 11, 295-302.
2. CAO, F., LIN, S., XIE, X., RAY, P., PATEL, M., ZHANG, X., DRUKKER, M., DYLLA, S.J., CONNOLLY, A.J., CHEN, X., WEISSMAN, I.L., GAMBHIR, S.S., and WU, J.C. (2006). In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113, 1005-1014.
3. CLACKSON, T., YANG, W., ROZAMUS, L.W., HATADA, M., AMARA, J.F., ROLLINS, C.T., STEVENSON, L.F., MAGARI, S.R., WOOD, S.A., COURAGE, N.L., LU, X., CERASOLI, F., Jr., GILMAN, M., and HOLT, D.A. (1998). Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc. Natl. Acad. Sci. U.S.A. 95, 10437-10442.
4. FERNANDES, S., AMIRAULT, J.C., LANDE, G., NGUYEN, J.M., FOREST, V., BIGNOLAIS, O., LAMIRAULT, G., HEUDES, D., ORSONNEAU, J.L., HEYMANN, M.F., CHARPENTIER, F., and LEMARCHAND, P. (2006). Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc. Res. 69, 348-358.
5. HAGEGE, A.A., CARRION, C., MENASCHE, P., VILQUIN, J.T., DUBOC, D., MAROLLEAU, J.P., DESNOS, M., and BRUNEVAL, P. (2003). Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361, 491-492.
6. HAGEGE, A.A., MAROLLEAU, J.P., VILQUIN, J.T., ALHERITIERE, A., PEYRARD, S., DUBOC, D., ABERGEL, E., MESSAS, E., MOUSSEAUX, E., SCHWARTZ, K., DESNOS, M., and MENASCHE, P. (2006). Skeletal myoblast transplantation in ischemic heart failure: Long-term follow-up of the first phase I cohort of patients. Circulation 114, 1108-1113.
7. HERREROS, J., PROSPER, F., PEREZ, A., GAVIRA, J.J., GARCIA-VELLOSO, M.J., BARBA, J., SANCHEZ, P.L., CANIZO, C., RABAGO, G., MARTI-CLIMENT, J.M., HERNANDEZ, M., LOPEZ-HOLGADO, N., GONZALEZ-SANTOS, J.M., MARTIN-LUENGO, C. and ALEGRIA, E. (2003). Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart J. 24, 2012-2020.
8. KOH, G.Y., KLUG, M.G., SOONPAA, M.H., and FIELD, L.J. (1993). Differentiation and long-term survival of C2C12 myoblast grafts in heart. J. Clin. Invest. 92, 1548-1554.
9. LAFLAMME, M.A., GOLD, J., XU, C., HASSANIPOUR, M., ROSLER, E., POLICE, S., MUSKHELI, V., and MURRY, C.E. (2005). Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167, 663-671.
10. LI, R.K., JIA, Z.Q., WEISEL, R.D., MICKLE, D.A., ZHANG, J., MOHABEER, M.K., RAO, V., and IVANOV, J. (1996). Cardiomyocyte transplantation improves heart function. Ann. Thorac. Surg. 62, 654-660; discussion 660-651.
11. MANGI, A.A., NOISEUX, N., KONG, D., HE, H., REZVANI, M., INGWALL, J.S., and DZAU, V.J. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9, 1195-1201.
12. McDEVITT, T.C., LAFLAMME, M.A., and MURRY, C.E. (2005). Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J. Mol. Cell. Cardiol. 39, 865-873.
13. MENASCHE, P., HAGEGE, A.A., SCORSIN, M., POUZET, B., DESNOS, M., DUBOC, D., SCHWARTZ, K., VILQUIN, J.T., and MAROLLEAU, J.P. (2001). Myoblast transplantation for heart failure. Lancet 357, 279-280.
14. MENASCHE, P., HAGEGE, A.A., VILQUIN, J.T., DESNOS, M., ABERGEL, E., POUZET, B., BEL, A., SARATEANU, S., SCORSIN, M., SCHWARTZ, K., BRUNEVAL, P., BENBUNAN, M., MAROLLEAU, J.P., and DUBOC, D. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41, 1078-1083.
15. MILASINCIC, D.J., CALERA, M.R., FARMER, S.R., and PILCH, P.F. (1996). Sdmulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol. Cell. Biol. 16, 5964-5973.
16. MURRY, C.E., WISEMAN, R.W., SCHWARTZ, S.M., and HAUSCHKA, S.D. (1996). Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest. 98, 2512-2523.
17. MURRY, C.E., FIELD, L.J., and MENASCHE, P. (2005). Cell-based cardiac repair: Reflections at the 10-year point. Circulation 112, 3174-3183.
18. PAGANI, F.D., DERSIMONIAN, H., ZAWADZKA, A., WETZEL, K., EDGE, A.S., JACOBY, D.B., DINSMORE, J.H., WRIGHT, S., ARETZ, T.H., EISEN, H.J., and AARONSON, K.D. (2003). Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 41, 879-888.
19. POUZET, B., VILQUIN, J.T., HAGEGE, A.A., SCORSIN, M., MESSAS, E., FISZMAN, M., SCHWARTZ, K., and MENASCHE, P. (2001). Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann. Thorac. Surg. 71, 844-850; discussion 850-841.
20. REINECKE, H., and MURRY, C.E. (2000). Transmural replacement of myocardium after skeletal myoblast grafting into the heart: Too much of a good thing? Cardiovasc. Pathol. 9, 337-344.
21. REINECKE, H., POPPA, V., and MURRY, C.E. (2002). Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J. Mol. Cell. Cardiol. 34, 241-249.
22. RUBART, M., PASUMARTHI, K.B., NAKAJIMA, H., SOONPAA, M.H., NAKAJIMA, H.O., and FIELD, L.J. (2003). Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ. Res. 92, 1217-1224.
23. RUBART, M., SOONPAA, M.H., NAKAJIMA, H., and FIELD, L.J. (2004). Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J. Clin. Invest. 114, 775-783.
24. SIMINIAK, T., KALAWSKI, R., FISZER, D., JERZYKOWSKA, O., RZEZNICZAK, J., ROZWADOWSKA, N., and KURPISZ, M. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am. Heart J. 148, 531-537.
25. SMITS, P.C., VAN GEUNS, R.J., POLDERMANS, D., BOUNTIOUKOS, M., ONDERWATER, E.E., LEE, C.H., MAAT, A.P., and SERRUYS, P.W. (2003). Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: A clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 42, 2063-2069.
26. SUZUKI, K., SMOLENSKI, R.T., JAYAKUMAR, J., MURTUZA, B., BRAND, N.J., and YACOUB, M.H. (2000). Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 102, III216-III221.
27. TAMBARA, K., SAKAKIBARA, Y., SAKAGUCHI, G., LU, F., PREMARATNE, G.U., LIN, X., NISHIMURA, K., and KOMEDA, M. (2003). Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108(Suppl. 1), II259-II263.
28. TEMPLETON, T.J., and HAUSCHKA, S.D. (1992). FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor, FGFR1. Dev. Biol. 154, 169-181.
29. VIRAG, J.I., and MURRY, C.E. (2003). Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am. J. Pathol. 163, 2433-2440.
30. WHITNEY, M.L., OTTO, K.G., BLAU, C.A., REINECKE, H., and MURRY, C.E. (2001). Control of myoblast proliferation with a synthetic ligand. J. Biol. Chem. 276, 41191-41196.
31. YAU, T.M., LI, G., WEISEL, R.D., REHEMAN, A., JIA, Z.Q., MICKLE, D.A., and LI, R.K. (2004). Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J. Thorac. Cardiovasc. Surg. 127, 1180-1187.
32. ZHANG, M., METHOT, D., POPPA, V., FUJIO, Y., WALSH, K., and MURRY, C.E. (2001). Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33, 907-921.